摘要
丙型肝炎病毒HCV是慢性肝炎、肝硬化以及肝细胞癌的主要原因。大量的研究指出许多能够在肝生理学上呈阳性结果的微型RNAs能够调节HCV感染或者被其调节。许多研究显示HCV利用宿主miRNAs 以及通过与HCV的RNA基因作用或者间接地控制于病毒复制相关的宿主通路从而调节HCV复制的表达,最终诱导与HCV相关的肝性疾病如肝纤维化、肝硬化或HCC。近期,在人类血清和血浆中检测到的细胞外miRNAs(循环miRNAs)被认为是病理条件下候选生物标记物,由于其性质非常稳定以及治疗的非侵入性。因为这些循环miRNAs, 大量的努力投入研究与HCV感染以及肝疾病相关的循环miRNAs模式的变化。本文综述了miRNAs在HCV相关的肝性疾病的发生和发展中的特点,并讨论了越来越多的那些能够区分与HCV感染和肝疾病相关的循环miRNA模式的证据。本文也强调了在HCV感染和相关疾病的诊断和预测中基于miRNA治疗形态和非侵入性生物标记物的进展。
关键词: 生物标记物,循环miRNAs
图形摘要
Current Drug Targets
Title:The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection
Volume: 18 Issue: 7
关键词: 生物标记物,循环miRNAs
摘要: Hepatitis C virus (HCV) is a worldwide major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Accumulating evidence indicates that a number of microRNAs (miRNAs), which are able to exert an effect on liver biology and pathology, can regulate or be regulated by HCV infection. Many studies demonstrate that HCV utilizes host miRNAs and modulates expression of miRNAs in infected hepatocytes for its infection and propagation. In turn, host miRNAs can directly regulate HCV replication through interaction with the HCV RNA genome or by indirectly controlling the host pathways associated with the virus replication, which eventually induce HCV-related liver diseases such as liver fibrosis, hepatic cirrhosis, or HCC. Recently, extracellular miRNAs (circulating miRNAs) detected in human serum and plasma are proposed as biomarker candidates for pathological conditions due to their remarkably stable nature and the non-invasiveness of their detection. Since these circulating miRNAs exhibit consistent levels between healthy individuals but significantly changed profiles in disease conditions, considerable effort has been employed to investigate the alteration in the circulating miRNA pattern that is related with HCV infection and associated liver diseases. In this review, we summarize the features of miRNAs critical for HCVassociated liver disease initiation and progress, and discuss growing evidence that distinctive circulating miRNA patterns are related with HCV infection and associated liver diseases. These will shed light on the development of miRNA-based therapeutic modalities and non-invasive biomarkers for the diagnosis and prognosis of HCV infection and associated diseases.
Export Options
About this article
Cite this article as:
The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection, Current Drug Targets 2017; 18 (7) . https://dx.doi.org/10.2174/1389450117666160401125213
DOI https://dx.doi.org/10.2174/1389450117666160401125213 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
Letters in Drug Design & Discovery Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews Is There a Role for Antioxidants in the Prevention of Infection-Associated Carcinogenesis and in the Treatment of Infection-Driven Tumors?
Current Topics in Medicinal Chemistry Ontogenic Development and Population Dynamics of Hepatic Dendritic Cells
Current Immunology Reviews (Discontinued) Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target
Mini-Reviews in Medicinal Chemistry 1,3,4-Thiadiazole Based Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-a] Pyridine Derivatives
Medicinal Chemistry Angiogenesis and Hypoxia in Glioblastoma: A Focus on Cancer Stem Cells
CNS & Neurological Disorders - Drug Targets Immune Modulation of Asian Folk Herbal Medicines and Related Chemical Components for Cancer Management
Current Medicinal Chemistry An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Histone Deacetylase Inhibitors and Anticancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Antioxidant Potential of Solvent Partitioned Extraction from Aqueous Extract of Gracilaria Tenuistipitata
Current Organic Chemistry Drug-Glycosidation and Drug Development
Mini-Reviews in Medicinal Chemistry Proteasome Inhibitors Therapeutic Strategies for Cancer
Recent Patents on Anti-Cancer Drug Discovery Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products
Current Drug Targets Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
Current Drug Targets Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials